These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction. Tirino V; Camerlingo R; Bifulco K; Irollo E; Montella R; Paino F; Sessa G; Carriero MV; Normanno N; Rocco G; Pirozzi G Cell Death Dis; 2013 May; 4(5):e620. PubMed ID: 23640462 [TBL] [Abstract][Full Text] [Related]
26. TGF-β-SNAIL axis induces Müller glial-mesenchymal transition in the pathogenesis of idiopathic epiretinal membrane. Kanda A; Noda K; Hirose I; Ishida S Sci Rep; 2019 Jan; 9(1):673. PubMed ID: 30679596 [TBL] [Abstract][Full Text] [Related]
27. TGFβ2-mediated production of hyaluronan is important for the induction of epicardial cell differentiation and invasion. Craig EA; Austin AF; Vaillancourt RR; Barnett JV; Camenisch TD Exp Cell Res; 2010 Dec; 316(20):3397-405. PubMed ID: 20633555 [TBL] [Abstract][Full Text] [Related]
28. FGFR signaling maintains a drug persistent cell population following epithelial-mesenchymal transition. Brown WS; Akhand SS; Wendt MK Oncotarget; 2016 Dec; 7(50):83424-83436. PubMed ID: 27825137 [TBL] [Abstract][Full Text] [Related]
29. An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition. Park CY; Min KN; Son JY; Park SY; Nam JS; Kim DK; Sheen YY Cancer Lett; 2014 Aug; 351(1):72-80. PubMed ID: 24887560 [TBL] [Abstract][Full Text] [Related]
31. Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer. Choi J; Park J; Cho I; Sheen Y Radiol Oncol; 2022 Apr; 56(2):185-197. PubMed ID: 35390248 [TBL] [Abstract][Full Text] [Related]
32. Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer. Nakano M; Kikushige Y; Miyawaki K; Kunisaki Y; Mizuno S; Takenaka K; Tamura S; Okumura Y; Ito M; Ariyama H; Kusaba H; Nakamura M; Maeda T; Baba E; Akashi K Oncogene; 2019 Feb; 38(6):780-793. PubMed ID: 30181548 [TBL] [Abstract][Full Text] [Related]
33. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells. Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286 [TBL] [Abstract][Full Text] [Related]
34. Hyaluronic acid synthase 2 promotes malignant phenotypes of colorectal cancer cells through transforming growth factor beta signaling. Kim YH; Lee SB; Shim S; Kim A; Park JH; Jang WS; Lee SJ; Myung JK; Park S; Lee SJ; Kim MJ Cancer Sci; 2019 Jul; 110(7):2226-2236. PubMed ID: 31102316 [TBL] [Abstract][Full Text] [Related]
35. Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer. Alkatout I; Wiedermann M; Bauer M; Wenners A; Jonat W; Klapper W Exp Mol Pathol; 2013 Feb; 94(1):168-73. PubMed ID: 22985790 [TBL] [Abstract][Full Text] [Related]
36. Regulation of transcription factor Twist expression by the DNA architectural protein high mobility group A2 during epithelial-to-mesenchymal transition. Tan EJ; Thuault S; Caja L; Carletti T; Heldin CH; Moustakas A J Biol Chem; 2012 Mar; 287(10):7134-45. PubMed ID: 22241470 [TBL] [Abstract][Full Text] [Related]
37. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771 [TBL] [Abstract][Full Text] [Related]
38. Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling. Kim IG; Kim SY; Choi SI; Lee JH; Kim KC; Cho EW Oncogene; 2014 Jul; 33(30):3908-17. PubMed ID: 24013232 [TBL] [Abstract][Full Text] [Related]
39. Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells. Kumar A; Xu J; Sung B; Kumar S; Yu D; Aggarwal BB; Mehta K Breast Cancer Res; 2012 Jan; 14(1):R4. PubMed ID: 22225906 [TBL] [Abstract][Full Text] [Related]
40. Cytokines and growth factors stimulate hyaluronan production: role of hyaluronan in epithelial to mesenchymal-like transition in non-small cell lung cancer. Chow G; Tauler J; Mulshine JL J Biomed Biotechnol; 2010; 2010():485468. PubMed ID: 20671927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]